[The differentiation of the effect of anti-human IgM on lymphocytes in vitro].
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology*; D001666:Binding Sites, Antibody; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D006041:Goats / Q000276:immunology; D006649:Histocompatibility Antigens / Q000032:analysis; D006801:Humans; D007106:Immune Sera; D007125:Immunogenetics; D007075:Immunoglobulin M; D037102:Lectins; D008213:Lymphocyte Activation; D008934:Mitogens; D011817:Rabbits / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D006649:Histocompatibility Antigens; D007106:Immune Sera; D007075:Immunoglobulin M; D037102:Lectins; D008934:Mitogens; D014316:Tritium; D003165:Complement System Proteins; D013936:Thymidine
Beitrag zur Differenzierung der Wirkung von Anti-Human-IgM auf Lymphozyten in vitro